Increase in anti-tuberculosis drug resistance in Botswana: results from the fourth National Drug Resistance Survey
Menzies H, Moalosi G, Anisimova V, Gammino V, Sentle C, Bachhuber M, Bile E, Radisowa K, Kachuwaire O, Basotli J, Maribe T, Makombe R, Shepherd J, Kim B, Samandari T, El-Halabi S, Chirenda J, Cain K. Increase in anti-tuberculosis drug resistance in Botswana: results from the fourth National Drug Resistance Survey. The International Journal Of Tuberculosis And Lung Disease 2014, 18: 1026-1033. PMID: 25189548, PMCID: PMC5531285, DOI: 10.5588/ijtld.13.0749.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overAntitubercular AgentsBotswanaChildChild, PreschoolDrug Resistance, Multiple, BacterialFemaleHealth Care SurveysHumansMaleMicrobial Sensitivity TestsMiddle AgedMycobacterium tuberculosisSputumTime FactorsTreatment OutcomeTuberculosis, Multidrug-ResistantTuberculosis, PulmonaryYoung AdultConceptsAnti-tuberculosis drug resistanceMultidrug-resistant tuberculosisPrevious anti-tuberculosis treatmentAnti-tuberculosis treatmentNew TB patientsDrug resistance surveyTB patientsDrug susceptibility testingDrug resistanceNew sputum smear-positive TB patientsAnti-tuberculosis drug susceptibility testingSputum smear-positive TB patientsNational drug resistance surveyHigh TB burden countriesMDR-TB diagnosisPositive TB patientsDrug-resistant TBTB burden countriesResistance surveyEmergence of resistanceTB controlBurden countriesDST resultsNew patientsMycobacterial culture